Mandate

Vinge advises Irisity in connection with new issues

November 07, 2017 Capital Markets and Public M&A

Vinge is advising Irisity AB (publ), listed on Nasdaq First North, in connection with a rights issue and a directed new issue of shares.

The rights issue is underwritten to 100% through subscription undertakings and underwriting guarantees. The directed issue occurs via Vätterledens Invest and Hans Andersson & Co AB, both long term strategic investors. An extraordinary general meeting will adopt a resolution concerning the issues on 24 November and a prospectus is expected to be published on 5 December with the subscription period commencing on 7 December. Irisity conducts operations within intelligent camera surveillance and develops camera solutions with the help of proactive working and self learning algorithms.

Vinge’s team consists of Anders Strid, Frida Bäckegren, Joel Zetterström (IP) and corporate assistant Camilla Andersson.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025